PKU HealthCare Corp.,Ltd. (SHE:000788)

Market Cap	3.63B
Revenue (ttm)	2.01B
Net Income (ttm)	151.46M
Shares Out	595.99M
EPS (ttm)	0.25
PE Ratio	23.97
Forward PE	n/a
Dividend	0.06 (1.01%)
Ex-Dividend Date	Jun 17, 2025

Volume	2,780,609
Average Volume	11,575,790
Open	6.15
Previous Close	6.09
Day's Range	6.04 - 6.15
52-Week Range	4.91 - 7.48
Beta	0.26
RSI	37.59
Earnings Date	Oct 31, 2025

About PKU HealthCare Corp.,Ltd.

PKU HealthCare Corp.,Ltd. researches, develops, manufactures, and sells pharmaceutical products in China. It offers products in various categories, including anti-tumor, psychoneurological, cardiovascular, immunosuppressive, antimicrobial, antipyretic and analgesic, digestive system, regulate immunity, oncology, anti-allergic, blood sugar regulation, mental disorder, and blood volume expansion. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 772
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000788

Financial Performance

In 2024, PKU HealthCare Corp.,Ltd.'s revenue was 2.06 billion, a decrease of -6.10% compared to the previous year's 2.19 billion. Earnings were 137.99 million, an increase of 211.10%.